Scanfil (SCANFL) Status Update summary

Strategic and operational highlights

• Launched 'Geared for Growth 2024-2028' strategy, focusing on segment, geographic, and offering diversification, acquisitions, and efficiency.

• Updated vision, mission, and values in 2024, introducing empowerment as a core value to foster decision-making at all organizational levels.

• Management structure reorganized into regional segments, with new leaders appointed, including CEO Christophe Sut and regional VPs.

• Acquisition of SRX Global in October 2024 expanded presence in Asia (Malaysia, Australia), supporting long-term growth ambitions.

• Customer segmentation prioritized medtech/life science, energy/cleantech, and industrial sectors for sustainable growth.

Financial and performance update

• 2024 turnover reached €901.6 million, with a CAGR of 13.8% since 2014.

• EBITA margin improved to 7.6% in 2024, with a CAGR of 12.6% in EBITA over the past decade.

• Achieved a margin level of 6.8%, matching the previous year's performance despite market challenges.

• Dividend per share has grown at a CAGR of 13.1% since 2014, with a 2024 payout ratio of 41% and a proposed increase to EUR 0.24.

• Continued investments in capabilities, facilities, and M&A to support future growth.

Organizational and regional developments

• Regional structure supports growth, with significant turnover and EBITA contributions from Central Europe (€303.3M), Northern Europe (€257.4M), APAC (€189.3M), and Americas (€35M).

• Employee base distributed across Europe, Americas, and APAC, supporting global operations.

• Customer group-specific sales organization and new management team structure implemented to support growth.

• Chief People Officer appointed to accelerate strategy execution.

• Capital Markets Day launched new growth strategy.